Adlai Nortye (ANL) Assets Growth (3y) (2025)
Adlai Nortye (ANL) Assets Growth (3y) (2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - |
| 3 | Akari Therapeutics | 1,023.69 Bn | 1,023.69 Bn | - |
| 4 | BeOne Medicines | 468.59 Bn | 463.80 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.01 Bn | 115.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.29 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.33 Bn | 63.33 Bn | - |
| 8 | Argenx Se | 55.70 Bn | 50.52 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn |
| 10 | Adlai Nortye | 1.18 Bn | 1.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.01% |